Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Are you Ready for the Renaissance in Small Molecule Drug Discovery? Haydn Boehm, Director of Product Marketing At first glance, it might seem that small molecule discovery has reached a plateau. In reality, the truth couldn’t be more different. With small molec... 3 days ago | 46 mins Demonstrating Analytical Comparability in Analytical Development Santoshkumar Khatwani at Sangamo Therapeutics and Svea Cheeseman at Refyn The presentation will focus on challenges in analytical comparability for gene therapy products. In addition, orthogonal methods along with some of th... February 14, 2023 6:00pm A Hybrid Approach to Continuous Biomanufacturing of Biosimilars Andrew Falconbridge at Alvotech and Melisa Caprio at Repligen There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end-to-end op... 2 weeks ago | 84 mins Platform Technology To Speed Up CMC Process Dr H. Fai Poon, President, QuaCell Biotech Ltd The commercial success of monoclonal antibodies has made biologics become attractive to pharmaceutical companies . The approval pathway is often requi... March 15, 2023 7:30am Adaptation of the analytical control strategy of a commercial vaccine... Jean-Francois Dierick at GSK Full Title: Adaptation of the analytical control strategy of a commercial vaccine using the principles of QbD. Challenges, lessons learned and improve... March 30, 2023 2:00pm Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... April 5, 2023 5:00pm A Valuation and Partnering Approach for Pre-Commercial Biotechnology Programs Julian Snow This session will outline how to determine a risk adjusted net present value for a pre-commercial biotech using @RISK to sensitize inputs and derive o... 3 months ago | 25 mins The Importance of Accurate Chemical Characterization of Medical Devices... Ron Brown, Toxicologist at Risk Science Consortium and Dries Cardoen, PhD, Sr. E&L Expert – Team leader at Nelson Labs Full title: The Importance of Accurate Chemical Characterization of Medical Devices Extractables Chemical characterization of medical devices, involv... 3 months ago | 134 mins Path to Smart Manufacturing and Intelligent Development within Industry 4.0 Dan Hill at Biogen, Chris McCready at Sartorius Stedim Biotech and Martin Gadsby at Optimal Industrial Technologies Ltd Path to Smart Manufacturing and Intelligent Development within Industry 4.0 - Building an Integrated Sensing Strategy Over the years there have been ... 5 months ago | 131 mins Annex 1 and Environmental Monitoring Program - Implementation And Justification. Benoit Ramond at Sanofi and Laurent Leblanc at bioMérieux Full Title: Annex 1 and Environmental Monitoring Program - Implementation And Justification of The Best Practices In Routine What is new? How to impl... 4 months ago | 118 mins Load more
